Christer Ahlberg

Christer Ahlberg is an accomplished executive with extensive experience in the pharmaceutical and medtech industries. Ahlberg currently serves as CEO of Cinclus Pharma, which focuses on developing innovative treatments for gastric acid-related diseases. Previously, Ahlberg held the CEO position at Sedana Medical, a company specializing in inhaled sedation technologies for intensive care patients. Ahlberg's leadership roles also include Chairman of the Board at PharmaControl MQL AB and Corporate CEO of the Unimedic Group, where significant revenue growth was achieved. Additional experience includes positions as Managing Director at Eisai AB and Business Unit Manager at Wyeth, along with various sales and marketing management roles throughout a career spanning over two decades. Ahlberg's educational background includes studies at Örebro University, Stockholm University, and Missouri State University.